Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-013783
Filing Date
2025-02-14
Accepted
2025-02-14 07:15:20
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0230488-10q_incannex.htm   iXBRL 10-Q 661373
2 CERTIFICATION ea023048801ex31-1_incannex.htm EX-31.1 11094
3 CERTIFICATION ea023048801ex31-2_incannex.htm EX-31.2 10893
4 CERTIFICATION ea023048801ex32-1_incannex.htm EX-32.1 4252
5 CERTIFICATION ea023048801ex32-2_incannex.htm EX-32.2 4530
  Complete submission text file 0001213900-25-013783.txt   4391685

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ixhl-20241231.xsd EX-101.SCH 46954
7 XBRL CALCULATION FILE ixhl-20241231_cal.xml EX-101.CAL 39181
8 XBRL DEFINITION FILE ixhl-20241231_def.xml EX-101.DEF 191293
9 XBRL LABEL FILE ixhl-20241231_lab.xml EX-101.LAB 365993
10 XBRL PRESENTATION FILE ixhl-20241231_pre.xml EX-101.PRE 206648
82 EXTRACTED XBRL INSTANCE DOCUMENT ea0230488-10q_incannex_htm.xml XML 466329
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41106 | Film No.: 25623187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)